Great Basin Scientific (NASDAQ: GBSN) is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. Great Basin’s vision is to make molecular diagnostic testing simple and cost-effective enough that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. For more information, visit the company’s website at www.gbscience.com